Bullish & Foolish
Full LGVN fundamentals All 466 on the Survival Watch

LGVNLONGEVERON INC.

Is Longeveron struggling financially?

Yes, by its own account. Longeveron told the SEC on 13 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$26.9M
Source filing
10-Q 13 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 3months

    If the burn speeds up

    Empty by Sep 2026

  • 5months

    If it eases off

    Empty by Nov 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$10.1M

÷

Cash burned over the last 12 months

$33.4M

What Longeveron told the SEC

…commitments for one year from the date these financial statements are available to be issued and therefore needs to raise additional funds to continue as a going concern. As a result, there is substantial doubt about the Company’s ability to continue as a going concern. 2. Summary of Significant Accounting Policies Basis of Presentation: The condensed financial statements were prepared in…

LONGEVERON INC., Form 10-Q, filed 13 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 87.6% share-count increase The company issued stock. Each share now owns 46.7% less of the business than a year ago, before any change in the price.
  • Cash burn is increasing It is spending 20% more cash per year than it was, so the runway above shortens even if nothing else changes.

Other Biotech/Pharma companies that filed the doubt